Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Treasury Shares (2022 - 2025)

TransMedics has reported Treasury Shares over the past 4 years, most recently at $1737.0 for Q4 2025.

  • For Q4 2025, Treasury Shares fell 58.25% year-over-year to $1737.0; the TTM value through Dec 2025 reached $1737.0, down 58.25%, while the annual FY2025 figure was $1737.0, 58.25% down from the prior year.
  • Treasury Shares for Q4 2025 was $1737.0 at TransMedics, down from $4160.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $328366.0 in Q4 2023 and troughed at $1737.0 in Q4 2025.
  • A 4-year average of $89644.5 and a median of $14237.5 in 2022 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: surged 1250.47% in 2023 and later tumbled 98.73% in 2024.
  • Year by year, Treasury Shares stood at $24315.0 in 2022, then surged by 1250.47% to $328366.0 in 2023, then tumbled by 98.73% to $4160.0 in 2024, then crashed by 58.25% to $1737.0 in 2025.
  • Business Quant data shows Treasury Shares for TMDX at $1737.0 in Q4 2025, $4160.0 in Q4 2024, and $328366.0 in Q4 2023.